The group consists of 5 scientists, 3 postdocs, 5 PhD students, 6 research engineers and one MD-PhD student.
We seek to reach a more fundamental understanding of the biological dynamics of breast cancer through high-throughput molecular analyses of DNA, mRNA, miRNA and protein. We
perform "state of the art" analyses of patient material, both on bulk tumors, single cells and liquid biopsies, at various stages of the disease, from consecutive series (OsloVal, Oslo0, Oslo1 and Oslo2) and from clinic trials with sampling before, during, and after therapy (the NeoAva and the IBCT-study).
Professor Anne-Lise Børresen-Dale, Email: email@example.com
Department of Cancer Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo,Norway
Phone: +47 2278 1373, Fax: +47 2278 1395, Switchboard: +47 2293 4000
Excellent Researcher Award and Early Career Award 2017
Jan 16, 2017
Antimicrobial resistance - how bad is the situation in the world of virus, fungus and mycoplasma?
Jan 11, 2017
Jan 11, 2017
Fatigue during and after breast cancer therapy - A prospective study
J Pain Symptom Manage (in press)
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
Clin Transl Immunology, 5 (11), e109